Security | APDN / Applied DNA Sciences, Inc. |
Insider | Beth Jantzen |
Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Beth Jantzen in APDN / Applied DNA Sciences, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Max |
Price at Max |
Max Profit ($) |
Max Return (%) |
---|---|---|---|---|---|---|---|
There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Beth Jantzen in APDN / Applied DNA Sciences, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Min |
Price at Min |
Max Loss Avoided ($) |
Max Loss Avoided (%) |
---|---|---|---|---|---|---|---|
There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Transaction History
File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-03-27 | 2023-03-23 | 4 | Jantzen Beth | APDN | Common Stock | D | 91,667 | 91,739 | ||||||
2021-11-03 | 2021-11-01 | 4 | Jantzen Beth | APDN | Non-Qualified Stock Option (right to buy) | D | 5.58 | 25,205 | 25,205 | |||||
2021-11-03 | 2021-11-01 | 4 | Jantzen Beth | APDN | Incentive Stock Option (right to buy) | D | 5.58 | 19,924 | 19,924 | |||||
2020-10-21 | 2020-10-19 | 4 | Jantzen Beth | APDN | Stock Option (right to buy) | D | 7.54 | 13,035 | 13,035 | |||||
2020-06-04 | 2020-06-03 | 4 | Jantzen Beth | APDN | Stock Option (right to buy) | D | 8.36 | 6,965 | 6,965 | |||||
2018-12-12 | 2018-12-10 | 4 | Jantzen Beth | APDN | Stock Option (right to buy) | D | 8.16 | 4,167 | 4,167 | |||||
2018-12-12 | 2018-12-10 | 4 | Jantzen Beth | APDN | Stock Option (right to buy) | D | 8.16 | -4,167 | 0 | |||||
2018-12-03 | 2018-11-29 | 4 | Jantzen Beth | APDN | Stock Option (right to buy) | D | 6.96 | 4,167 | 4,167 | |||||
2018-12-03 | 2018-11-29 | 4 | Jantzen Beth | APDN | Stock Option (right to buy) | D | 6.96 | -4,167 | 0 | |||||
2018-10-17 | 2018-10-14 | 4 | Jantzen Beth | APDN | Stock Option (right to buy) | D | 5.13 | 4,167 | 4,167 | |||||
2018-10-17 | 2018-10-14 | 4 | Jantzen Beth | APDN | Stock Option (right to buy) | D | 5.13 | -4,167 | 0 | |||||
2018-08-31 | 2018-08-29 | 4 | Jantzen Beth | APDN | Stock Option (right to buy) | D | 1.19 | 100,000 | 100,000 | |||||
2017-06-29 | 2017-06-28 | 4 | Jantzen Beth | APDN | Common Stock | D | 1.7600 | 2,841 | 5 | 2,841 | ||||
2016-12-22 | 2016-12-20 | 4 | Jantzen Beth | APDN | Stock Option (right to buy) | D | 2.05 | 60,000 | 60,000 | |||||
2016-03-15 | 2015-06-16 | 4 | Jantzen Beth | APDN | Stock Option (right to buy) | D | 3.45 | 30,000 | 30,000 | |||||
2015-12-23 | 2015-12-21 | 4 | Jantzen Beth | APDN | Stock Option (right to buy) | D | 2.99 | 50,000 | 50,000 | |||||
2015-02-23 | 3 | Jantzen Beth | APDN | Common Stock | D | 0 |